Effects of EGFR Gene Polymorphisms on Efficacy and Prognosis 
in Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs

An increasing number of patients with advanced non-small cell lung cancer (NSCLC) have been treated with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). However, significant differences in response to EGFR-TKIs have been shown among advanced NSCLC patients. Recently, selecti...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Liangshan DA, Lin XU
Format:	Artigo
Jezik:	Chinês
Izdano:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2013-03-01
Serija:	Chinese Journal of Lung Cancer
Teme:	EGFR-TKIs Lung neoplasms Polymorphisms Efficacy Prognosis
Online dostop:	http://dx.doi.org/10.3779/j.issn.1009-3419.2013.03.09
Oznake:	Označite Brez oznak, prvi označite!